Standout Papers

Amyloid-Related Imaging Abnormalities in 2 Phase 3 Studies Evaluating Aducanumab in Patients With Early Alzheimer... 2021 2026 2022 2024383
  1. Amyloid-Related Imaging Abnormalities in 2 Phase 3 Studies Evaluating Aducanumab in Patients With Early Alzheimer Disease (2021)
    Stephen Salloway, Spyros Chalkias et al. JAMA Neurology

Immediate Impact

5 from Science/Nature 62 standout
Sub-graph 1 of 21

Citing Papers

Alzheimer’s Disease Detection Using Deep Learning on Neuroimaging: A Systematic Review
2024 Standout
Neuroinflammation in Neurodegenerative Disorders: Current Knowledge and Therapeutic Implications
2024 Standout
4 intermediate papers

Works of Patrick Burkett being referenced

Amyloid-Related Imaging Abnormalities in 2 Phase 3 Studies Evaluating Aducanumab in Patients With Early Alzheimer Disease
2021 Standout

Author Peers

Author Last Decade Papers Cites
Patrick Burkett 268 60 94 99 4 387
Wan Chi Lau 251 33 68 144 6 440
Robert G. Riekse 223 88 181 52 7 454
Devon Gessert 252 28 79 72 9 445
Claire Alderton 228 16 74 73 7 340
Peter Seubert 366 71 191 52 9 441
Nathan Evaniew 134 35 55 75 8 387
E.M.-F. King 271 36 171 43 5 366
Related Disorders 226 23 86 86 5 392
Diana Thyssen 287 20 68 93 5 371
Karen Campbell 215 10 73 94 5 398

All Works

Loading papers...

Rankless by CCL
2026